Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
72.09
P/B ratioShare price divided by book value per share.
2.74
P/S ratioMarket value divided by annual revenue.
8.46
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
40.52
EV / RevenueEnterprise value against annual revenue.
7.58
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
1.39%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
48.37%
Operating marginRevenue left after operating costs.
-4.37%
Net marginRevenue left after every cost, including tax and interest.
10.41%
Return on equityProfit as a percentage of shareholders’ equity.
3.37%
Return on assetsProfit as a percentage of total assets.
1.32%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
2.96
Quick ratioThe same, excluding inventory.
2.27
Debt to equityTotal borrowings against shareholders’ equity.
0.15
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$0.11
Book value per shareShareholders’ equity divided by shares outstanding.
$2.90
Shares outstandingShares currently issued.
830,297,145
Market capitalisationShare price times shares outstanding.
$6.58B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
1,328
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.80%
Payout ratioShare of profit paid out as dividends.
What is Zhejiang Ausun Pharmaceutical Co., Ltd.'s P/E ratio?
Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) trades on a price-to-earnings ratio of 72.09.
What is Zhejiang Ausun Pharmaceutical Co., Ltd.'s return on equity?
Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) reports a return on equity of 3.37%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Zhejiang Ausun Pharmaceutical Co., Ltd. carry?
Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) has a debt-to-equity ratio of 0.15, which compares total borrowings with shareholders' equity.
What is Zhejiang Ausun Pharmaceutical Co., Ltd.'s profit margin?
Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) keeps 10.41% of revenue as net profit after every cost, including tax and interest.